In the TME (tumor microenvironment), CCL2 can be produced by both cancer and stromal cells including TAMs and shows opposing pro- or antitumoral effects depending on its type and stage; however, high CCL2 expression is generally an unfavorable prognostic factor in different types of cancers [38,39,49]. Here, CCL2 is linked to cancer.